TrialNature communications2026

Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.

Francesc Català-Moll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.